PanoramicaGraficoNotizieSchermataTrader

UBS Knock-Out AZN/  DE000UM8QCH9  /

EUWAX
23/12/2024  09:50:43 Var.-0.13 Denaro22:00:19 Lettera22:00:19 Sottostante Prezzo di esercizio Expiration date Tipo di opzione
4.23EUR -2.98% -
Quantità in denaro: -		 -
Quantità in lettera: -		 AstraZeneca PLC 108.9872 USD 31/12/2078 Put
Newsfile Corp 23/12 ROSEN, NATIONAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Impo...
Newsfile Corp 21/12 ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Inquire About Securities Class Ac...
Newsfile Corp 20/12 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Inquire About Securities Cla...
Newsfile Corp 18/12 ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Inquire About Securities Cl...
TeleTrader 04/12 Europe opens mostly up with French confidence vote in focus
TeleTrader 18/11 AstraZeneca's cell lung cancer drug sent for EU approval
TeleTrader 12/11 Europe closes deep in red amid earnings, data
TeleTrader 12/11 AstraZeneca's revenue in Q3 rises 21% to $13.5B
GlobeNewswire 27/08 Structure Therapeutics Appoints Angus C. Russell to Board of Directors
GlobeNewswire 13/08 Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
TeleTrader 25/07 AstraZeneca's Q2 revenue up by 13% to $12.94B
GlobeNewswire 20/06 Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire 12/06 Connect Biopharma Announces New Leadership and Chair of the Board of Directors
TeleTrader 20/05 AstraZeneca to build $1.5B plant in Singapore
GlobeNewswire 15/05 Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire 13/05 Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/05 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
TeleTrader 25/04 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 01/04 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire 28/03 Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
GlobeNewswire 25/03 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, In...
GlobeNewswire 25/03 Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
GlobeNewswire 19/03 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
TeleTrader 19/03 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 15/03 American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...